Buy, Sell, Or Hold Insulet (PODD) Stock? [Forbes]
Insulet Corporation (PODD)
Last insulet corporation earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insulet.com/investor-relations
Company Research
Source: Forbes
Measuring blood sugar levels regularly is essential in the treatment of diabetes. Photo: Jens Kalaene/dpa-Zentralbild/ZB (Photo by Jens Kalaene/picture alliance via Getty Images) picture alliance via Getty Images Insulet stock (NASDAQ: PODD) surged nearly 10% on Friday, November 8, after the company posted an upbeat Q3 and raised its sales outlook. It reported sales of $544 million and adjusted earnings of $0.90 per share, compared to the consensus estimates of $518 million and $0.77, respectively. Insulet is benefiting from increased adoption of its insulin delivery system Omnipod. Its latest product – Omnipod 5 – is the only automated insulin delivery system approved for both type 1 and type 2 diabetes. It was approved by the U.S. FDA in August this year. Insulet's revenue of $544 million reflected a 26% y-o-y growth, with both the U.S. and International Omnipod sales seeing strong growth of 23% and 36%, respectively. The aging population in the U.S. and an overall rise in awa
Show less
Read more
Impact Snapshot
Event Time:
PODD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PODD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PODD alerts
High impacting Insulet Corporation news events
Weekly update
A roundup of the hottest topics
PODD
News
- Insulet Corporation (NASDAQ:PODD) Delivered A Better ROE Than Its Industry [Yahoo! Finance]Yahoo! Finance
- Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at JPMorgan Chase & Co. from $280.00 to $330.00. They now have an "overweight" rating on the stock.MarketBeat
- Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at Citigroup Inc. from $283.00 to $310.00. They now have a "buy" rating on the stock.MarketBeat
- Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at Wells Fargo & Company from $290.00 to $305.00. They now have an "overweight" rating on the stock.MarketBeat
- Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at Canaccord Genuity Group Inc. from $269.00 to $304.00. They now have a "buy" rating on the stock.MarketBeat
PODD
Earnings
- 11/7/24 - Beat
PODD
Sec Filings
- 12/17/24 - Form 4
- 12/16/24 - Form 144
- 12/11/24 - Form 4
- PODD's page on the SEC website